AzTrials
AzTrials

Postoperative DeliriumPREDICtNCT03704324

Incidence and Risk Factors of PostopeRativE Delirium in ICU in China

An observational study of Postoperative Delirium and Intensive Care Psychiatric Disorder, run by Shanghai Zhongshan Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Postoperative delirium (POD) is a common postoperative complication that can occur in patients of any age. POD brings great burden to patients and their families, as the following cognitive decline may persist for months to years to impede patients returning to previous life quality and employment. Read more about this study

Who is it for?
Ages 18 years and older
How many people
1,000 participants
Where
1 siteChina
Study dates
1 Nov 2018to 1 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients aged above 18 who are admitted to surgical SICUs after operation will be screened for eligibility.

Who may be able to join

  • Aged above 18
  • Surgical patients
  • Admitted to ICU after surgery

Who cannot join

  • Preoperative delirium or dementia patients
  • Unable to fully participate in delirium testing, including blind, deaf, illiterate or inability to understand Chinese
  • Undergoing surgery procedures do not require admission to SICU
  • Transfer to SICU from wards after surgery

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • 180 Fenglin Road

    Shanghai, 20032

    Shining Cai, MSc, 86-021-64041990 ext. 2724, cai.shining@zs-hospital.sh.cn

    Yuxia Zhang, PhD

    Recruiting

Other trials in China

About this study

Postoperative delirium (POD) is a common postoperative complication that can occur in patients of any age. POD brings great burden to patients and their families, as the following cognitive decline may persist for months to years to impede patients returning to previous life quality and employment. The PREDICt study aims to characterize the incidence and profiles of POD in ICU, and to find out risk factors, especially any are modifiable, and any have value for developing prediction model. Our final aim is to comprehensively and deeply explore the etiology of POD to guide prevention of delirium among postoperative patients.

Read the detailed description

Delirium is an acute and fluctuating alteration of mental state characterized by a disturbance in attention, level of consciousness and cognition. Postoperative delirium (POD) is a common postoperative complication that can occur in patients of any age, from children to elderly. POD was proved to be associated with several worse outcome, including increased mechanically ventilated duration, hospital length of stay (LOS) and cost. Moreover, the each day with delirium is independently associated with an increased hazard of death by 10%. Although studies on delirium substantially increased in the past decade, many research gaps still exist in this area due to the heterogeneity of their results. First, the incidence varies broad range because the targeted population are different. In China, up to now, no large sample studies to investigate the incidence and risk factors of POD in ICU. Moreover, although there have been numerous studies exploring the potential risk factors of POD, most of them are still with inconclusive evidence. The Benzodiazepine use and blood transfusion administration are the only two modifiable factors with strong evidence. Hence, still needs further studies to focus on etiology of POD to find out modifiable and non-modifiable factors to verify the presumed factors. Since there is lack of effective treatments for POD, prevention remains the best strategy to cope with delirium. Predictive models that include delirium risk factors can guide us to early prevention of high risk patients. There were two high-quality studies on prediction models for ICU delirium, named PRE-DELIRIC model and E-PRE-DELIRIC model. However, both of the models are conducted in general ICU, did not fully consider the factors of surgery.

The PREDICt study aims to find out risk factors, especially any are modifiable, and any have value for developing prediction model. Our primary aim is to determine the incidence and severity of Post-Operative Delirium (POD) in ICU after surgery, and identify the associated outcomes and burdens of POD in ICU by evaluating the impact on postoperative outcome, ICU and hospital length of stay, medical expenses. Our secondary aim is to investigate the modifiable and non-modifiable risk factors for the occurrence of POD during ICU stay and develop delirium prediction model for ICU patients. Our final aim is to comprehensively and deeply explore the etiology of POD to guide prevention of delirium among postoperative patients.

Keywords
Incidence and profile, Risk factors, Prediction model
Medical subject headings
Emergence Delirium

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of postoperative delirium

    Investigators screen delirium by CAM-ICU twice a day, each time during day and night.

    Investigators defined patients have delirium if they had at least one positive screening during ICU stay.

    Measured: up to 20 days postoperatively

Secondary outcomes (2)
  1. Severity of postoperative delirium

    Assess by CAM-ICU-7 if CAM-ICU is positive. Categorized as no delirium: 0-2, mild to moderate delirium: 3-5, and severe delirium: 6-7.

    Measured: up to 20 days postoperatively

  2. duration of postoperative delirium

    Defined as time (in days) from the first positive CAM-ICU until the beginning of two consecutive days of negative CAM-ICU.

    Measured: up to 20 days postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Oct 2018
  2. Study start1 Nov 2018
  3. Primary completion1 Dec 2022 (estimated)
  4. Study completion1 Jan 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03704324
Sponsor's protocol ID
2018ZSLC08
Acronym
PREDICt
Status last verified
Dec 2021
First submitted
1 Sep 2018
Last updated
3 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Study protocol has been published in Journal of advanced nursing

Publications

  • Zhu A, Liu Y, Guan T, Ju M, Du Y, Latour JM, Hong Y, Lin X, Cai S, Zhang Y. Data-driven subtypes of postoperative delirium in surgical ICU patients: a secondary analysis of a prospective cohort study. Anaesth Crit Care Pain Med. 2026 Jul 13:101894. doi: 10.1016/j.accpm.2026.101894. Online ahead of print.

    PubMed 42442477
  • Cai S, Cui H, Pan W, Li J, Lin X, Zhang Y. Two-stage prediction model for postoperative delirium in patients in the intensive care unit after cardiac surgery. Eur J Cardiothorac Surg. 2022 Dec 2;63(1):ezac573. doi: 10.1093/ejcts/ezac573.

    PubMed 36579859
  • Wang H, Zhao QY, Luo JC, Liu K, Yu SJ, Ma JF, Luo MH, Hao GW, Su Y, Zhang YJ, Tu GW, Luo Z. Early prediction of noninvasive ventilation failure after extubation: development and validation of a machine-learning model. BMC Pulm Med. 2022 Aug 8;22(1):304. doi: 10.1186/s12890-022-02096-7.

    PubMed 35941641

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Delirium and Intensive Care Psychiatric Disorder, run by Shanghai Zhongshan Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Shining Cai (+86 18818260719, cai.shining@zs-hospital.sh.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of postoperative delirium (time frame: up to 20 days postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03704324, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in